Literature DB >> 28656656

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration.

Laurel H Messer1, Gregory P Forlenza1, R Paul Wadwa1, Stuart A Weinzimer2, Jennifer L Sherr2, Korey K Hood3, Bruce A Buckingham3, Robert H Slover1, David M Maahs3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28656656     DOI： 10.1111/pedi.12535

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN： 1399-543X            Impact factor:   4.866


× No keyword cloud information.
  11 in total

1.  Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.

Authors:  Gregory P Forlenza; Faye M Cameron; Trang T Ly; David Lam; Daniel P Howsmon; Nihat Baysal; Georgia Kulina; Laurel Messer; Paula Clinton; Camilla Levister; Stephen D Patek; Carol J Levy; R Paul Wadwa; David M Maahs; B Wayne Bequette; Bruce A Buckingham
Journal:  Diabetes Technol Ther       Date:  2018-04-16       Impact factor: 6.118

Review 2.  Diabetes Technology and Therapy in the Pediatric Age Group.

Authors:  David M Maahs; Rayhan Lal; Shlomit Shalitin
Journal:  Diabetes Technol Ther       Date:  2019-02       Impact factor: 6.118

3.  A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm.

Authors:  Laurel H Messer; Cari Berget; Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2019-05-29       Impact factor: 6.118

4.  Ongoing Debate About Models for Artificial Pancreas Systems and In Silico Studies.

Authors:  Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2018-03       Impact factor: 6.118

5.  MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy.

Authors:  Aria Saunders; Laurel H Messer; Gregory P Forlenza
Journal:  Expert Rev Med Devices       Date:  2019-09-30       Impact factor: 3.166

6.  Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.

Authors:  Gregory P Forlenza; Dan Raghinaru; Faye Cameron; B Wayne Bequette; H Peter Chase; R Paul Wadwa; David M Maahs; Emily Jost; Trang T Ly; Darrell M Wilson; Lisa Norlander; Laya Ekhlaspour; Hyojin Min; Paula Clinton; Nelly Njeru; John W Lum; Craig Kollman; Roy W Beck; Bruce A Buckingham
Journal:  Pediatr Diabetes       Date:  2017-11-20       Impact factor: 4.866

Review 7.  Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.

Authors:  Gregory P Forlenza; Laurel H Messer; Cari Berget; R Paul Wadwa; Kimberly A Driscoll
Journal:  Curr Diab Rep       Date:  2018-09-26       Impact factor: 4.810

8.  Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association.

Authors:  Jane L Chiang; David M Maahs; Katharine C Garvey; Korey K Hood; Lori M Laffel; Stuart A Weinzimer; Joseph I Wolfsdorf; Desmond Schatz
Journal:  Diabetes Care       Date:  2018-08-09       Impact factor: 19.112

Review 9.  Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.

Authors:  Jennifer L Sherr; Lutz Heinemann; G Alexander Fleming; Richard M Bergenstal; Daniela Bruttomesso; Hélène Hanaire; Reinhard W Holl; John R Petrie; Anne L Peters; Mark Evans
Journal:  Diabetologia       Date:  2022-10-06       Impact factor: 10.460

10.  Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.

Authors:  Bruce A Buckingham; Mark P Christiansen; Gregory P Forlenza; R Paul Wadwa; Thomas A Peyser; Joon Bok Lee; Jason O'Connor; Eyal Dassau; Lauren M Huyett; Jennifer E Layne; Trang T Ly
Journal:  Diabetes Technol Ther       Date:  2018-08-02       Impact factor: 6.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.